Interestingly, tamoxifen has shown some efficacy in reducing ERα-negative tumor growth by inhibiting angiogenesis in an ER-negative fibrosarcoma model 11 and in female mice with ER-negative lung cancer 12. This evidence concerns the gene ERAL1 and neoplasm.